California Initiative to Advance Precision Medicine Expert Selection Committees

Elaine R. Mardis, PhD is a nationally recognized leader in genomics and cancer research whose work has been foundational in advancing next-generation sequencing and precision oncology. She is a Professor of Pediatrics at The Ohio State University College of Medicine and serves as Co-Executive Director of the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital. Her research focuses on genomic characterization of cancer, identification of actionable molecular drivers, and translation of genomic discoveries into clinically relevant diagnostic and therapeutic strategies, with a strong emphasis on pediatric and young adult populations. Dr. Mardis has played key leadership roles in large-scale genomic initiatives and has authored numerous high-impact publications in cancer genomics and genomic medicine. Her work continues to shape how genomic data are integrated into clinical cancer care. Dr. Mardis previously served on 2018 Evaluation Committee as well as the Cancer Disparities Selection and Evaluation Committees.

Olusola Ajilore, MD, PhD is a Professor of Psychiatry at the University of Illinois Chicago and a nationally recognized leader in depression research and translational neuroscience. He serves as a Professor at the University of Illinois Center for Depression and Resilience and holds multiple leadership roles, including Director of the Mood and Anxiety Disorders Program and Director of the Clinical Research Core. His research focuses on the pathophysiology of major depressive disorder, particularly in the context of medical comorbidities and aging, using advanced structural and functional neuroimaging and brain connectivity methods. Dr. Ajilore received medical and doctoral training in neuroscience and psychiatry and has led interdisciplinary research aimed at identifying patient-specific neural targets to improve diagnosis and treatment. He has contributed to national scientific review efforts and previously served on the Depression Selection Committee.

Caitlin G. Allen, PhD, MPH is an Associate Professor at Wake Forest University School of Medicine and a social and behavioral scientist recognized for leadership in implementation science, genomics, and precision public health. Her research focuses on translating evidence-based genomic applications into real-world clinical and community settings to advance health equity. Dr. Allen’s scholarship emphasizes participatory implementation science, workforce development through training community health workers in genomics, and effective communication of genomic information among diverse populations. Her work has been featured in Nature and Harvard Public Health Magazine, reflecting her contributions as a thought leader in precision public health. She received her PhD and MPH from Emory University and has held faculty and research positions at the Medical University of South Carolina, the Centers for Disease Control and Prevention, Boston University, and the Massachusetts Department of Public Health.

José A. Bauermeister, PhD, MPH, FSBM is the Albert M. Greenfield Professor of Human Relations at the University of Pennsylvania, serving as Professor of Psychiatry at the Perelman School of Medicine and Director of the Eidos LGBTQ+ Health Initiative, where he provides national leadership in digital health and behavioral science. His research integrates public health, social science, and technology to design, test, and scale interventions that reduce health disparities among LGBTQ+ communities and youth. Dr. Bauermeister received advanced training in public health and behavioral science and has built a career centered on community-engaged, technology-assisted research addressing social determinants of health. He has authored more than 300 peer-reviewed publications and has led or contributed to over $240 million in federally funded research. A Fellow of the Society of Behavioral Medicine and an Aspen Institute Health Innovators Fellow, his work advances social justice–oriented approaches to improving population health and promoting equity.

Sunny Chieh Cheng, PhD is an Associate Professor in the Nursing and Healthcare Leadership program at the University of Washington Tacoma, recognized for her expertise in psychiatric and mental health nursing and her leadership in mental and behavioral health equity research. Her work focuses on community-engaged strategies to improve mental health outcomes for school-aged youth and underserved populations, including developing, evaluating, and translating evidence-based interventions for early-stage psychosis, caregiver support, and school behavioral health promotion. Dr. Cheng employs mixed methods and participatory frameworks to partner with communities and institutions in addressing structural barriers to behavioral health access and care. She has led and collaborated on funded projects that build community capacity, integrate technology into mental health support, and promote equity in service delivery across diverse populations, advancing both research innovation and practical solutions in mental health equity.

Shawn Chiang, PhD, MPH is a social behavioral scientist dedicated to reducing health disparities in cancer prevention and control through translational digital health and communication science. As an Assistant Professor in the Department of Health Behavior at the Texas A&M School of Public Health, Dr. Chiang focuses on understanding how individual, interpersonal, and social factors influence health behaviors, particularly those related to cancer prevention. Dr. Chiang completed a PhD in Health Behavior and Health Promotion College of Education and Health Professions at the University of Arkansas and a Master of Public Health at the Milken Institute School of Public Health George Washington University, Washington, DC. His formal professional training includes a post-doctoral- fellowships at both the Arkansas Research Center for Public Health & Technology and the Drexel University Health & Digital Media Innovation (HDMI) Lab, a fellowship with the Computational Social Science Summer Institute (SICSS) at the University of Pennsylvania, and a CDC Evaluation Fellow with the Division of Emergency Operations at the Centers for Disease Control and Prevention.

Elizabeth Gross Cohn, RN, PhD, FAAN is a Professor of Medicine at the City University of New York egchool of Medicine, with a distinguished record of leadership in equity-centered research and academic administration. Her research focuses on health equity, precision medicine, genomics, and community-engaged approaches to preventing and managing chronic disease, particularly cardiovaegcular disease, through public health training and social marketing strategies. Dr. Cohn received doctoral training in nursing and has held senior academic and leadership roles across major institutions, including service as Rudin Professor of Community Health at Hunter College and Associate Provost for Research at CUNY. Earlier, she served as Executive Director of the Center for Health Innovation at Adelphi University and held faculty and research egcientist appointments at Columbia University. A Robert Wood Johnson Foundation Nurse Faculty egcholar and White House Champion of Change in Precision Medicine and Health Equity, she has led federally funded and CDC-supported initiatives and previously served on the Cancer Disparities Selection and Evaluation Committees.

Jack Cordes, PhD, MS is an Assistant Research Professor in the Department of Public Health and Community Medicine at Tufts University School of Medicine and a recognized leader in spatial epidemiology. His research focuses on substance use disorders and the opioid crisis, emphasizing community-engaged approaches to understand overdose risk, access to harm reduction, and treatment services. Dr. Cordes applies expertise in epidemiology, biostatistics, geographic information systems, and advanced Bayesian and multilevel spatiotemporal methods to develop predictive models and inform public health interventions. He serves as analytic lead for the NIDA-funded Predict-to-Prevent study, identifying overdose hotspots across Massachusetts, and is Principal Investigator of the project Xylazine in Lowell: Community-Engaged Spatial Analysis and Harm Reduction. Dr. Cordes earned his PhD in Epidemiology and MS in Biostatistics from Harvard T.H. Chan School of Public Health and is committed to translating complex data into actionable strategies that improve health equity and community outcomes.

Juan Carlos Espinoza Salomon, MD is Chief Research Informatics Officer at Lurie Children’s Hospital, Associate Director of the Center for Biomedical Informatics and Data Science, and Director of the Consortium for Technology & Innovation in Pediatrics (CTIP) at Northwestern University. His research integrates health information systems, digital health, pediatric medical devices, social determinants of health, and health equity to improve outcomes for children, especially those from marginalized communities. Dr. Espinoza’s work spans pediatric obesity, children with medical complexity, and global health, leveraging informatics and technology to translate research into practical solutions. He earned his MD from USC Keck School of Medicine, completed a pediatric residency at Children’s Hospital Los Angeles, and previously served as Assistant Professor of Clinical Pediatrics at CHLA and USC. Dr. Espinoza combines clinical expertise, innovation, and data-driven research to advance child and population health equity.

Darrell Hudson, PhD, MPH is the James S. Jackson Collegiate Professor and Chair of the Department of Health Behavior and Health Equity at the University of Michigan School of Public Health. Prior to his appointment at Michigan, he was Professor of Public Health at the Brown School at Washington University in St. Louis and Director for the Center for the Study of Race, Ethnicity, and Equity at Washington University. Dr. Hudson’s career is dedicated to the elimination of racial/ethnic inequities in health. His research agenda centers on how social determinants of health affect multiple health outcomes. Dr. Hudson completed his doctoral studies at the University of Michigan School of Public Health, where he also received his MPH. He earned a BA in Psychology from Morehouse College. Prior to his faculty appointment, Dr. Hudson completed a postdoctoral fellowship with the Kellogg Health Scholars Program at the University of California at the San Francisco and Berkeley campuses.

Douglas Knutson, PhD, LHSP, ABPP is an Associate Professor in the School of Community Health Sciences, Counseling, and Counseling Psychology at Oklahoma State University, where he teaches, conducts research, and engages in community outreach focused on behavioral health and health disparities. A Licensed Health Service Psychologist and Board-Certified in Counseling Psychology, Dr. Knutson’s scholarship emphasizes rural health, LGBTQ+ resilience, transgender and nonbinary affirming care, and mental health outcomes among marginalized and underserved populations. His research employs qualitative and mixed methods approaches to examine social and contextual influences on health and well-being, including self-harm and psychological resilience in sexual and gender minority youth, and to develop supportive interventions for families and communities. He also holds leadership and service roles in academic and professional settings that promote rural mental health, diversity, equity, and inclusion in the behavioral sciences, advancing both research and practical strategies to improve mental health equity.

Jewel Mullen, MD, MPH, MPA holds faculty appointments in the Departments of Population Health and Internal Medicine and serves as Director of Health Equity for Ascension Seton and Director of Health Equity and Quality for Central Health, Travis County’s health district, where she advocates for underserved communities in Austin, Texas. Her work focuses on advancing health equity, public health policy, and systems-level interventions to reduce disparities. Dr. Mullen previously served as Principal Deputy Assistant Secretary for Health at the U.S. Department of Health and Human Services and as Commissioner of the Connecticut Department of Public Health, and she has held faculty appointments at New York University, University of Virginia, Yale University, and Tufts University Schools of Medicine. She completed a postdoctoral fellowship in psychosocial epidemiology at Yale University, earned her MD at Mount Sinai School of Medicine (Alpha Omega Alpha), and holds an MPH from Yale University and an MPA from Harvard Kennedy School. Her career spans clinical care, research, and public health leadership with a focus on equity.

Dr. Akinlolu (“Ojo”) Ojo has served as Executive Dean of the University of Kansas School of Medicine since 2019. Previously, he was Associate Vice President for Clinical Research at the University of Arizona and spent 23 years on the faculty at the University of Michigan as the inaugural Florence E. Bingham Research Professor and Professor of Medicine and Epidemiology. He earned his MD from the University of Lagos, an MPH from the University of Alabama at Birmingham, completed internal medicine training at the University of Kentucky, and a fellowship in nephrology at the University of Michigan, where he also earned a PhD in epidemiology and an executive MBA. Dr. Ojo’s research focuses on racial health disparities, kidney disease, transplantation, precision medicine, and global health. He has led over $230 million in NIH and federal funding, including AASK, All of Us, and H3Africa. As a nationally recognized clinician and scholar, he has over 220 publications and is a member of the National Academy of Medicine and several other prestigious societies.

Wei Perng, MPH, PhD is an Associate Professor of Epidemiology with tenure at the Colorado School of Public Health and serves as Deputy Director of the Lifecourse Epidemiology of Adiposity & Diabetes Center at the University of Colorado. Her research focuses on nutritional epidemiology, childhood obesity, and the structural and environmental determinants of metabolic disease in children and adolescents, applying lifecourse and metabolomics approaches to understand and prevent cardiometabolic risk. Dr. Perng completed postdoctoral training at Harvard University, where she also worked as an Analyst in the Department of Population Health, and earned her MPH and PhD in Epidemiology from the University of Michigan. She has published over 200 peer-reviewed studies, contributing significantly to the fields of nutritional epidemiology, metabolomics, and lifecourse research. Through her scholarship, Dr. Perng advances understanding of early-life exposures and their impact on metabolic health, informing strategies for prevention and health equity in pediatric populations.

Paula S. Ramos, PhD is a human geneticist specializing in the etiology of autoimmune diseases, with a dedicated focus on addressing health disparities in systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). Her multidisciplinary research integrates molecular, statistical and population genetics, with genetic and social epidemiology, together with ELSI (Ethical, Legal, and Social Implications) frameworks to identify the complex genetic and societal drivers of disease in historically underrepresented populations. Dr. Ramos champions representative precision medicine by leveraging academic-community partnerships to advance genetic literacy—a commitment demonstrated by her work training community members, health workers, and graduate students.

Elizabeth H. Ruder, PhD, MPH, RDN is an Associate Professor and School Head of the Wegmans School of Health and Nutrition in the College of Health Sciences and Technology at the Rochester Institute of Technology, where she leads academic and research programs in nutrition and public health. Her research focuses on nutritional epidemiology, community-based interventions, eating behavior, nutritional assessment, and cancer prevention, with an emphasis on translating diet–disease research into effective nutrition education and behavior change strategies. Dr. Ruder earned a BS from Cornell University, a PhD from Pennsylvania State University, and an MPH from the Johns Hopkins Bloomberg School of Public Health, and she is a Registered Dietitian Nutritionist. She completed training in the National Cancer Institute’s Cancer Prevention Fellowship Program and previously served on the faculty at the University of Pittsburgh before joining RIT in 2015. Her scholarship integrates research, education, and community engagement to advance public health nutrition and cancer prevention efforts.

Dorothy D. Sears, PhD is a Professor of Nutrition and Executive Director of Clinical and Community Translational Research in the College of Health Solutions at Arizona State University. She is an internationally recognized expert in cardiometabolic disease and cancer research, employing a transdisciplinary approach that integrates molecular biology, behavioral nutrition, systems biology, gut microbiome analyses, and population health. Dr. Sears’ research focuses on dietary and behavioral interventions, the health effects of circadian alignment of food intake, and chronic disease prevention in women, including studies on intermittent fasting and sedentary behavior in postmenopausal populations. She directs the Women’s Health Collaboratory and serves as an investigator on multiple federally and nationally funded clinical and translational studies. Dr. Sears is actively engaged in mentoring trainees across career stages and in community outreach, translating research findings into evidence-based strategies to improve public health and promote wellness in diverse populations.

Arash Shaban-Nejad, PhD, MPH, MS, FAMIA is an Associate Professor at the University of Tennessee Health Science Center and Director of Population and Precision Health within the Center for Biomedical Informatics. His research integrates epidemiology, biomedical informatics, artificial intelligence, and population health analytics to advance disease surveillance, chronic disease research, and health equity–focused decision-making. Dr. Shaban-Nejad develops and applies advanced analytic methods for high-dimensional health data, real-world evidence applications, and data-driven tools to address structural determinants of health and disparities across diverse clinical populations. He holds doctoral and master’s degrees with training in public health and computational sciences and collaborates across clinical, academic, and public health settings to translate research into policy and practice. He has previously contributed to scientific review and advisory efforts, including service on the ACEs and Depression Selection Committees, and his work continues to promote equity-oriented, data-informed approaches in population and precision health.

Bonnielin K. Swenor, PhD, MPH is a Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health and Director of the Johns Hopkins Disability Health Research Center, where she provides national leadership in advancing disability-inclusive health equity research. Her research focuses on disability as a critical and often overlooked dimension of health disparities, emphasizing inequities experienced by people with disabilities across the life course. Dr. Swenor integrates epidemiologic methods, population health data, and community-engaged research approaches to examine how structural, social, and environmental factors shape health outcomes for disabled populations. She received advanced training in public health and epidemiology and has led interdisciplinary initiatives that strengthen disability measurement, inclusion, and representation in research and policy. Through her scholarship and leadership, Dr. Swenor has helped position disability as a central component of health disparities research, generating policy-relevant evidence to inform more inclusive public health practice, clinical research, and cancer prevention and care efforts.

Martin Tristani-Firouzi, MD is a Professor at the University of Utah School of Medicine and a nationally recognized leader in cardiovascular genetics and precision medicine. He serves as Co-Director of the Utah Center for Genomic Medicine, holds the H.A. and Edna Benning Presidential Chair, and directs the Pediatric Cardiology Genotype–Phenotype Core, where he has led efforts integrating genomic discovery with detailed clinical phenotyping to improve diagnosis and management of inherited cardiac disease. His research focuses on translational genomics, genotype–phenotype correlations, and the clinical implementation of precision medicine in pediatric and adult cardiovascular care. Dr. Tristani-Firouzi received medical training in pediatrics and cardiology and has more than two decades of experience advancing genomic medicine within academic health systems. He previously served as Chair of the American Heart Association Research Committee, helping to shape national research priorities in cardiovascular science. His work emphasizes equitable access to genomic medicine, with particular attention to youth and Latino and Spanish-speaking populations.

Celina I. Valencia, DrPH is a faculty member and researcher at the University of Arizona, recognized for her work at the intersection of genomics, bioinformatics, and health disparities, with a focus on women’s health. Her research leverages genomic and computational approaches to understand biological and structural drivers of inequities in health outcomes among underrepresented populations. Dr. Valencia engages in interdisciplinary research that integrates population health, data science, and equity-focused frameworks, aiming to expand inclusion of Spanish-speaking, Latino, and Native American communities in precision medicine research. She has contributed to initiatives such as the All of Us Spanish Convening and actively participates in outreach and community-engaged efforts to foster continued collaboration and equitable research practices. Her work advances the integration of genomics with public health to address health disparities and promote more inclusive precision medicine.

Stacey J. Winham, PhD is an Associate Professor of Biostatistics and a statistical geneticist at the Mayo Clinic in Rochester, Minnesota, recognized for her research on the genetic etiology of complex diseases and the development of advanced analytic methods for high-dimensional genomic data. Her work focuses on identifying gene–gene and gene–environment interactions, sex-specific genetic effects, and the role of the X chromosome in disease, integrating machine learning and diverse genomic data types. Dr. Winham applies these approaches to studies of psychiatric disorders, breast cancer, and ovarian cancer and holds leadership roles in quantitative methods training through Mayo Clinic’s Graduate School of Biomedical Sciences and Center for Clinical and Translational Science. She is deeply committed to mentoring graduate students, postdoctoral fellows, and junior faculty and actively contributes to collaborative research consortia in psychiatric genomics and cancer genetics, advancing both methodological innovation and translational impact in genomic medicine.

Gloria D. Coronado, PhD is a Professor at the University of Arizona and an epidemiologist with a long record of designing and evaluating interventions to improve cancer screening participation and follow-up. She leads and co-directs systems-based programs to raise colorectal cancer screening and follow-up rates across diverse health plans and community clinics. Her research focuses on community-engaged epidemiology, biostatistics, and health disparities, with emphasis on improving screening participation and follow-up among underserved and hard-to-reach populations. Her work applies population segmentation and data-driven outreach approaches that advance equity in preventive health. She integrates community-engagement strategies and culturally tailored materials to extend the reach of evidence-based cancer prevention to Latino, rural, and other priority populations. She also serves in scientific leadership roles and on national advisory committees that guide cancer prevention research and evaluation. Dr. Coronado previously served on the Cancer Evaluation Committee.

Elizabeth “Liz” Aquino, PhD, RN, FAAN is a Clinical Associate Professor in the Department of Biobehavioral Nursing Science and serves as Associate Dean for Academic Affairs in the College of Nursing at the University of Illinois–Chicago. She has held leadership roles at the state and national levels, including service as President of the American Nurses Association–Illinois and leadership within national Hispanic/Latinx nursing organizations. Her work focuses on nursing education, academic mentorship, community engagement, and health equity, with emphasis on strengthening academic pathways for diverse students and advancing graduate and professional training. Her scholarly interests include workforce development, social determinants of health, and equity-centered policy and educational reform. Dr. Aquino is trained in nursing and is a Fellow of the American Academy of Nursing. She was recently appointed to the HRSA National Advisory Council on Nurse Education and Practice.

Marie Barnard, PhD is an Associate Professor of Pharmacy Administration and Research Associate Professor in the Research Institute of Pharmaceutical Sciences at the University of Mississippi and serves as Graduate Program Coordinator for the Department of Pharmacy Administration. She is the Distinguished Cotton Lecturer in Pharmacy Administration and a faculty affiliate of the Sarah Isom Center for Women and Gender Studies. Her research interests include social and behavioral determinants of health, public health, vaccination behavior, program evaluation, health outcomes, and the health sciences educational pipeline. Her work includes implementation science-informed evaluations of interventions related to HPV vaccination, intimate partner violence, safe prescribing behaviors, and leveraging community pharmacy settings to improve health outcomes. Dr. Barnard earned a Master’s degree in epidemiology from the University of Tennessee Health Sciences Center and a PhD in Pharmacy Administration from the University of Mississippi. She has served as principal or co-investigator on more than 50 grants and contracts and is the principal investigator on an NIH-funded youth participatory action project to develop a young adult-centered health promotion research agenda and enhance interest in health sciences careers.

Elena Cyrus, PhD, MPH is an Associate Professor in the Department of Population Health Sciences, College of Medicine, at the University of Central Florida and a global health epidemiologist. She also serves as a Visiting Professor at Universidad Peruana de Ciencias Aplicadas and mentors undergraduate, graduate, and medical trainees in international clinical and research settings. Her research focuses on health disparities, behavioral health, and prevention of infectious diseases, substance use, and HIV and sexually transmitted infections among key populations globally. Her work integrates population-based epidemiology with mixed-methods observational approaches and emphasizes syndemic conditions affecting marginalized communities in the Latin American and Caribbean region and beyond. Dr. Cyrus completed extensive predoctoral and postdoctoral training in global health, reproductive health, and HIV and substance use disparities. In 2023, she was the sole recipient of the National Institute on Drug Abuse DP2 Avenir Award for contributions to syndemic research.

Andrew T. Dewan, PhD, MPH is a Professor of Chronic Disease Epidemiology at Yale University and serves as Director of Graduate Studies, with experience in graduate education, mentoring, and leadership in doctoral training programs. He has extensive experience in interdisciplinary research. His research focuses on genetic epidemiology and genomics, centered on identifying genetic and genomic factors associated with complex diseases using large-scale population and family-based studies. His work includes applications across a wide range of clinical conditions. Dr. Dewan is trained in genetic epidemiology and genomics. He has served in national scientific review and advisory roles related to genetics and health research, contributing methodological and substantive expertise to studies of health and disease.

Susan Everson-Rose, PhD, MPH is a Professor in the Division of General Internal Medicine at the University of Minnesota Medical School and serves as Associate Director of the Program in Health Disparities Research and an Affiliate Professor in the School of Public Health. She contributes to training and mentoring in health equity research and leadership development. Her research integrates psychosocial and social epidemiology to investigate how psychological, social, and environmental factors influence risk for chronic conditions, including women’s health outcomes and cardiovascular disease. Her research spans studies of stress mechanisms, social determinants, and mind-body influences on health. Dr. Everson-Rose is trained in psychophysiology and social epidemiology and conducts health disparities and chronic disease research supported by national funding.

Bertha Hidalgo, PhD, MPH, FACE is an Associate Professor in the Department of Epidemiology and Associate Dean for the Office of Access and Engagement in the University of Alabama at Birmingham School of Public Health. She is also an Associate Scientist with the UAB Nutrition Obesity Research Center and serves as President of the American College of Epidemiology. Her research centers on cardiovascular disease, with expertise in genetic epidemiology and dissemination science. Dr. Hidalgo holds degrees from Stanford University, the University of Southern California, and the University of Alabama at Birmingham. Her research has been funded by the NIH, American Heart Association, and Robert Wood Johnson Foundation, among others.

Rohan D. Jeremiah, PhD, MPH is a Professor of Human Development Nursing Science and serves as Associate Dean for Global Health in the College of Nursing at the University of Illinois–Chicago. He has extensive global health experience, including service as a Peace Corps volunteer and leadership of health programs across Sub-Saharan Africa, South Asia, Latin America, the Eastern Caribbean, and the United States. His research focuses on health equity, trauma, behavioral health, and community-engaged research among marginalized and vulnerable populations worldwide, with attention to intimate partner violence, HIV/AIDS, cancer disparities, refugee health, and LGBTQ+ and minority men’s health. Dr. Jeremiah is trained in applied medical anthropology and global public health. His work has informed policy and practice through collaborations with organizations such as the United Nations, PEPFAR, USAID, and the Inter-American Development Bank, and he mentors students and professionals in global and community-engaged public health research.

Daisy Le, PhD, MPH, MA is an Associate Professor of Health Disparities and Oncology in the School of Nursing at George Washington University and holds affiliated faculty appointments with the Milken Institute School of Public Health and the GW Cancer Center. She advances research and teaching on population health, communication, and equity-centered interventions. Her research focuses on community-engaged cancer prevention and culturally responsive strategies to improve access to cancer screening and preventive services among minority, low-income, and underserved populations, including mobile health technologies and participatory methods. Dr. Le’s work has been supported by national funding agencies and has produced peer-reviewed publications on health disparities and community health equity. She served as principal investigator on initiatives such as the MySHARE HPV self-sampling project to increase cervical cancer screening uptake among women living with HIV.

Gwen Lomberk, PhD is the Joel and Arlene Lee Chair in Pancreatic Cancer Research and serves as Chief, Division of Research, and Director of Basic Science Research in the Department of Surgery at the Medical College of Wisconsin. She is also a Professor of Surgery and Pharmacology and Toxicology. Her research focuses on epigenetic mechanisms driving pancreatic ductal adenocarcinoma, with emphasis on chromatin regulation, histone methylation, and cell cycle control as therapeutic targets. Her work includes epigenomic-based pharmacology and investigations of genetic-to-epigenetic signaling pathways, including synergistic inhibition of Aurora A kinase and H3K9 methylation to induce mitotic catastrophe and suppress tumor growth. Dr. Lomberk is trained as a cancer biologist. She advances basic and translational cancer research and contributes to experimental therapeutics in pancreatic cancer.

Caleb C. McKinney, PhD, MPS is a Professor in the Department of Rehabilitation Medicine at Georgetown University School of Medicine and serves as Senior Associate Dean for Training, Program Development, and Academic Innovation. He leads initiatives to enhance training environments, foster inclusive excellence, and support the academic and professional development of graduate students, postdoctoral scholars, and junior faculty. His work focuses on enhancing biomedical research training, developing innovative professional development and academic programs, and graduate student development, with emphasis on strengthening pathways into research careers. Dr. McKinney has served as principal investigator and co-principal investigator on federally funded training programs, including the Initiative for Maximizing Student Development (IMSD), contributing to structured training, mentorship, and capacity building for trainees from diverse backgrounds. His leadership supports institutional and national efforts to strengthen the pipeline of diverse scientists and clinicians.

Michelle Odlum, EdD, MPH is an Assistant Professor in the School of Nursing at the George Washington University and contributes to training graduate students and researchers in health disparities, public health research methods, and community-engaged scholarship. Her work spans public health informatics, precision science, and evaluation of social determinants of health. Her research focuses on health equity and health disparities and applies data science, artificial intelligence, and big data analytics to explore patterns in social and health data, including social media and electronic health records. Her work supports prevention, containment, and control of infectious diseases and chronic conditions in high-risk and underserved groups and includes funded work and publications addressing aging with HIV and chronic disease outcomes. Dr. Odlum is trained in nursing and public health informatics.

Beth Pineles, MD, PhD, is a Maternal Fetal Medicine specialist and Assistant Professor of Obstetrics and Gynecology at the University of Pennsylvania's Perelman School of Medicine, with a secondary appointment in Biostatistics and Epidemiology. She holds both an M.D. and Ph.D. in Epidemiology from USC's Keck School of Medicine, bringing rigorous methodological training to her clinical research. Dr. Pineles's research focuses on maternal health outcomes, pregnancy complications, and the deimplementation of ineffective medical practices. She has secured funding from the NIH, PCORI, and major foundations. She also serves as Director of the Penn Medicine Placenta Accreta Spectrum Center of Excellence and is a Senior Scholar at Penn's Center for Clinical Epidemiology and Biostatistics.

Anne Saw, PhD is an Associate Professor of Psychology and Psychology Co-Associate Chair at DePaul University and serves as Director of the Chicago Asian American Psychology Lab. She teaches graduate and undergraduate courses in community psychology, diversity, and advanced psychological topics. Her research focuses on health and mental health disparities, community engagement, and culturally responsive psychological science, with emphasis on Asian American immigrants, refugees, and other underserved populations. Her work examines structural, sociocultural, and community factors shaping health and mental health outcomes and informs community-driven interventions. Dr. Saw is trained in psychology and works with community partners in Chicago and beyond to develop evidence-based, community-driven interventions that promote health, well-being, and healing.

Peter X.-K. Song, PhD is a Professor of Biostatistics at the University of Michigan and contributes methodological leadership for interdisciplinary research teams across biomedical, clinical, and population health research settings. He contributes to graduate education and mentorship in biostatistics and quantitative health sciences. His research focuses on statistical methodology for complex and large-scale data, including longitudinal and correlated data analysis, spatial statistics, and big data analytics. His work advances biostatistical theory and applied methods used across health research. Dr. Song is trained in biostatistics. He has served in professional and scientific review roles related to statistical science and health research.

Qianqian Song, PhD is an Assistant Professor in the Department of Health Outcomes and Biomedical Informatics at the University of Florida College of Medicine and serves as Director of Translational Bioinformatics at the UF Health Cancer Center. She also serves as Director of the Cancer Data Commons and co-leads the UFHCC Cancer AI Working Group and the UFHCC Computational Biology Unit. Her research focuses on artificial intelligence-driven biomedical informatics to advance precision medicine, including the development of deep learning, machine learning, and statistical tools for multi-modal integration of large-scale biomedical data. Her work integrates genomics, transcriptomics, proteomics, single-cell and spatial imaging, and population-level electronic health records. Dr. Song teaches graduate courses in translational bioinformatics and foundations of biomedical informatics.

Louisa A. Stark, PhD is a Professor of Human Genetics and Adjunct Professor of Population Health Sciences at the University of Utah School of Medicine where she holds a H.A. and Edna Benning Presidential Endowed Chair. She recently retired from her long-time position as Director of the Genetic Science Learning Center, where she led initiatives that translate genetics, genomics, biology, and health concepts into engaging and accessible educational materials for students and the public that are used around the world. The center has recently been renamed the Stark Science Learning Center in her honor. She also initiated and led the Community Collaboration and Engagement Team of the Utah Clinical and Translational Science Institute, which facilitates collaborations between academic researchers and community stakeholders, with a focus on genetics and genomics. Dr. Stark’s work spans science and health education, community engagement, and partnerships that co-design learning resources and outreach activities.

David T. Takeuchi, PhD is a Professor at the University of Washington and has led and contributed to multiple interdisciplinary and federally funded studies. He is actively involved in graduate education and mentorship and has played a role in developing training programs focused on population health inequities. His research focuses on health disparities, mental health, and social determinants of health among diverse populations. His work examines how race, ethnicity, immigration status, and socioeconomic conditions shape mental health outcomes, health service use, and well-being across the life course. Dr. Takeuchi is trained as a social scientist and population health researcher. His work includes studies examining risk and resilience factors in Asian American, Latino, and other underserved communities.

Suzanne Vang, PhD is an Assistant Professor in the Department of Population Health at NYU Grossman School of Medicine and serves in professional roles including editorial board review for Cancer Control and Frontiers in Oncology – Cancer Epidemiology and Prevention. She is also a scientific merit reviewer for the Patient-Centered Outcomes Research Institute (PCORI) and contributes to multiple cancer control and prevention collaborations. Her research focuses on the development and evaluation of multilevel interventions to reduce cancer morbidity and mortality, integrating quantitative and qualitative methods to inform targeted and scalable strategies for improving cancer outcomes. The overarching goal of her work is to advance precision in cancer prevention, early detection, and treatment effectiveness across diverse populations. Dr. Vang contributes to the NYU Langone Perlmutter Cancer Center, the NYU Center for the Study of Asian American Health, the NYC Citywide Colorectal Cancer Control Coalition, and the New York State Cancer Consortium.

Wei-Qi Wei, MD, PhD, FAMIA, FACMI is a Professor in the Department of Biomedical Informatics at Vanderbilt University Medical Center and serves as Director of the Precision Phenotyping Core. He leads multiple NIH-funded projects, including R01- and P50-level awards within national consortia such as eMERGE and MPRINT. His research focuses on precision medicine, electronic health record phenotyping, and translational genomics, integrating artificial intelligence, machine learning, natural language processing, pharmacogenomics, and large- scale clinical and genomic data. His work has advanced drug repurposing, individualized treatment prediction, and cross-institutional algorithm portability. Dr. Wei is trained as a biomedical informatics physician-scientist. He has authored more than 200 peer-reviewed publications, is an Associate Editor for Nature Digital Medicine, and is a Fellow of the American Medical Informatics Association and American College of Medical Informatics.

Aggie J. Yellow Horse, PhD is an Associate Professor in the School of Social Transformation at Arizona State University and teaches courses related to racial and ethnic studies, immigration, and health disparities. She has received external research support and recognition for her contributions to understanding racial health inequities and population health dynamics. Her research addresses the social determinants of racial health disparities and structural inequities in health, focusing on how racism and systemic inequality influence physical and mental health outcomes. Her scholarship integrates social demography and public health perspectives to examine health inequities and community contexts shaping health, including impacts for Asian American, Native American, and Pacific Islander communities. Dr. Yellow Horse is trained in social demography and public health perspectives.

Olusola Ajilore, MD, PhD is a Professor of Psychiatry at the University of Illinois Chicago and a nationally recognized leader in depression research and translational neuroscience. He serves as a Professor at the University of Illinois Center for Depression and Resilience and holds multiple leadership roles, including Director of the Mood and Anxiety Disorders Program and Director of the Clinical Research Core. His research focuses on the pathophysiology of major depressive disorder, particularly in the context of medical comorbidities and aging, using advanced structural and functional neuroimaging and brain connectivity methods. Dr. Ajilore received medical and doctoral training in neuroscience and psychiatry and has led interdisciplinary research aimed at identifying patient-specific neural targets to improve diagnosis and treatment. He has contributed to national scientific review efforts and previously served on the Depression Selection Committee.

Dr. Anthony is a Professor and Vice Chair for Psychology, and the Director of the Office of Psychological Science and Practice in the Department of Psychiatry at the University of Colorado School of Medicine. He is also Chief of Psychology for the Pediatric Mental Health institute at the Colorado Children's Hospital. His research focuses on how mental health disparities affect vulnerable populations and ways to improve the systems and practices that ultimately improve health outcomes. He received his bachelor’s degree in biology from the University of Pennsylvania and a PhD in psychology from Columbia University. His work also focuses on ways to empower youth and families in decision-making, including programs to help providers and families build effective partnerships to enhance outcomes. More recently, his work focuses on best practices to support primary care standards, schools, and parents in enhancing children’s mental health. Dr. Anthony has served as a member of NIH and PCORI study sections and serves as an ad hoc grant reviewer for the National Science Foundation, Veterans Administration, and the Administration for Children, Youth and Families.

Dr. Baker is an Associate Professor of Psychiatry at Harvard Medical School. He is also Director of the Laboratory for Functional Neuroimaging and Bioinformatics and Scientific Director of the McLean Institute for Technology in Psychiatry (ITP). Dr. Baker co-founded the ITP, a first-of-its-kind research and development center to develop tools and novel applications for consumer technology in psychiatric research and care delivery. He received his undergraduate degree in neuroscience at Brown University and his MD/PhD in neurobiology from the Washington University in St. Louis. Dr. Baker uses bioinformatical approaches and functional imaging to understand what causes the behavioral differences in the brains of people with lifelong psychiatric conditions like schizophrenia. He and his lab use techniques such as latent construct modeling, machine learning, and dynamical systems analysis to develop translational approaches to help individuals.

Dr. Barksdale is a licensed clinical psychologist and a Program Director in the Division of Community Health and Population Science at the National Institute of Minority Health and Health and Disparities. She earned her bachelor’s degree in psychology at the University of North Carolina at Chapel Hill and her master’s degree in public health from Johns Hopkins Bloomberg School of Public Health. She received her doctorate in clinical psychology from George Washington University. She has used her expertise to evaluate and consult on children’s mental health projects focusing on depression and suicide, disparities in child-serving systems, and culturally and linguistically appropriate interventions for at-risk youth and their families. Dr. Barksdale’s current work and research interests are focused on identifying, disseminating, and supporting community-based and community-engaged, multilevel interventions to eliminate health disparities, with a particular focus on the role of structural and social determinants of health.

Dr. Gamble-George is an Associate Research Scientist in Public Health at the Yale University School of Public Health. She is an internationally acclaimed scientist with over a decade of experience across clinical, administrative, and research sectors of the healthcare field, discovering cures for the most common health diseases and disorders She has shared her research approaches to medicine with diverse audiences around the globe, including Nobel Prize Winners. She holds a Bachelor of Science in Biochemistry and Biology with Honors in Mathematics from Xavier University of Louisiana and a Master of Health Administration from the University of South Florida College of Public Health. During her doctoral studies at Vanderbilt University, she co-founded SciX, LLC, a biotech company searching for methods to combat brain disorders and other health issues.

Dr. Fox is an Associate Professor of Healthcare Data Analytics in the School of Healthcare Leadership at the MGH Institute of Health Professionals. As a social psychologist, Dr. Fox is interested in the conceptualization, measurement, and consequences of mental illness stigma. She obtained a bachelor’s in psychology from College of the Holy Cross, and her Masters and PhD in social psychology from the University of Connecticut. Her current research uses advanced statistical models to examine the longitudinal relationships between stigma and mental health in young adults in order to determine the optimal timing for stigma interventions and increase rates of treatment seeking. She also serves as a statistician in the Women’s Health Sciences Division of the National Center for Post Traumatic Stress Disorders (PTSD), where her research focuses on PTSD, trauma, and women’s health.

Dr. Hernandez Suarez is an Associate Professor in Obstetrics and Gynecology and the Executive Associate Dean for Students at FIU Herbert Wertheim College of Medicine. She is also a board-certified obstetrician and gynecologist. She earned her bachelor’s degree at Swarthmore College and completed her MD at the Johns Hopkins University School of Medicine. She trained in Obstetrics and Gynecology at the University of Iowa Hospital and Clinics. She also holds a Master of Business Administration with specialization in Health Administration and Policy from the University of Miami. With skills in both hospital administration and academic research, her primary goal is to build bridges among hospitals, academia, and the community to create value for systems, patients, and learners. Dr. Hernandez Suarez is the Founding Chair of the Miami-Dade Health Action Network, a 2008 National Public Hospital Fellow "Future Leader of Public Hospitals" and a board member of the National Hispanic Medical Association.

Darrell Hudson, PhD, MPH is the James S. Jackson Collegiate Professor and Chair of the Department of Health Behavior and Health Equity at the University of Michigan School of Public Health. Prior to his appointment at Michigan, he was Professor of Public Health at the Brown School at Washington University in St. Louis and Director for the Center for the Study of Race, Ethnicity, and Equity at Washington University. Dr. Hudson’s career is dedicated to the elimination of racial/ethnic inequities in health. His research agenda centers on how social determinants of health affect multiple health outcomes. Dr. Hudson completed his doctoral studies at the University of Michigan School of Public Health, where he also received his MPH. He earned a BA in Psychology from Morehouse College. Prior to his faculty appointment, Dr. Hudson completed a postdoctoral fellowship with the Kellogg Health Scholars Program at the University of California at the San Francisco and Berkeley campuses.

Dr. Kerig is a Professor of Clinical Psychology at the University of Utah, where she directs the Risk to Resilience Laboratory. She earned her B.A. in Psychology from UC Irvine and Ph.D. in Clinical Psychology from UC Berkeley. Dr. Kerig is a developmental psychopathologist who studies the developmental processes that contribute to risk or resilience across the lifespan, particularly among youth exposed to trauma. Dr. Kerig also has an abiding interest in resilience and how it can be promoted through intervention. Her current research is focused on investigating the mechanisms accounting for the link between trauma and youth involvement in the justice system. Dr. Kerig also served on the Adverse Childhood Experiences Selection Committee for CIAPM.

Dr. Lim is an Assistant Professor at the NYU Grossman School of Medicine. She is currently leading the scientific tracks on Gender Equity and Mental Health at the Department of Population Health's Section for Health Equity. She is also a steering committee member of the Asian American Native Hawaiian Pacific Islander ‘OHANA Center of Excellence on mental health and substance use. Her research focuses on how multiple marginalization impacts mental and sexual health outcomes, drawing from intersectionality and syndemics frameworks to address gender-related health issues among hard-to-reach populations. Dr. Lim’s research interests also include reproductive and sexual health, mental health, and substance use. Her work uses mixed methods and community-engaged research approaches to advance health equity of individuals from mixed-marginalized populations. Dr. Lim obtained her PhD from Johns Hopkins University and an MPH from Columbia University.

Dr. Nahas is a Neuromodulation Researcher, Professor & Executive Vice Chair for Clinical Affairs at the Department of Psychiatry & Behavioral Sciences at the University of Minnesota. He received his Medical Degree from Saint Joseph University in Lebanon and then completed an internship in Psychiatry at L’Institut Paul Silvadon, a Lacanian day hospital, and Hôpital Charles Foix, both in Paris, France. He then completed a residency in Psychiatry at Baylor College of Medicine in Houston, Texas. Before becoming faculty at the University of Minnesota, he was previously at the Medical University of South Carolina and at the American University of Beirut Medical Center, where he helped develop the department's clinical, educational, and research portfolio. Dr. Nahas’ scientific interests lie in translational research of mood dysregulation and depressive disorders, with unique expertise in functional neuroimaging and brain stimulation across various modalities.

Dr. Sanchez is a Research Investigator and Director of Diversity and Inclusiveness in Research for Baylor Scott & White Health’s Research Institute (BSWRI) in Dallas, Texas. She is a clinician-researcher, with over 15 years of experience as a bilingual clinical social worker. Her research interests are in integrated health care, investigating effective interventions aimed at reducing disparities and improving uptake in evidence-based mental health treatments in primary care through sociocultural and linguistically adapted models for the treatment of co-morbid mental and physical illness. Dr. Sanchez’s research agenda has focused on small scale interventions in primary care that reduce mental health disparities at the health delivery system level. She also represents BSWRI on the governing board of the Health Care Systems Research Network, a network of 20 non-profit healthcare delivery systems.

Anne Saw, PhD is an Associate Professor of Psychology and Psychology Co-Associate Chair at DePaul University and serves as Director of the Chicago Asian American Psychology Lab. She teaches graduate and undergraduate courses in community psychology, diversity, and advanced psychological topics. Her research focuses on health and mental health disparities, community engagement, and culturally responsive psychological science, with emphasis on Asian American immigrants, refugees, and other underserved populations. Her work examines structural, sociocultural, and community factors shaping health and mental health outcomes and informs community-driven interventions. Dr. Saw is trained in psychology and works with community partners in Chicago and beyond to develop evidence-based, community-driven interventions that promote health, well-being, and healing.

Arash Shaban-Nejad, PhD, MPH, MS, FAMIA is an Associate Professor at the University of Tennessee Health Science Center and Director of Population and Precision Health within the Center for Biomedical Informatics. His research integrates epidemiology, biomedical informatics, artificial intelligence, and population health analytics to advance disease surveillance, chronic disease research, and health equity–focused decision-making. Dr. Shaban-Nejad develops and applies advanced analytic methods for high-dimensional health data, real-world evidence applications, and data-driven tools to address structural determinants of health and disparities across diverse clinical populations. He holds doctoral and master’s degrees with training in public health and computational sciences and collaborates across clinical, academic, and public health settings to translate research into policy and practice. He has previously contributed to scientific review and advisory efforts, including service on the ACEs and Depression Selection Committees, and his work continues to promote equity-oriented, data-informed approaches in population and precision health.

Dr. Shortreed is a Biostatistics Investigator at Kaiser Permanente Washington Health Research Institute and Affiliate Professor in the Department of Biostatistics at the University of Washington. She uses statistics and machine learning methods to address health science problems, with a special emphasis on analyzing complex longitudinal data, such as electronic health records. She is leading a project to develop statistical methods for constructing personalized treatment strategies, using data captured from electronic health records. She obtained her PhD in statistics from the University of Washington. Prior to her current role, she spent two years in the Department of Epidemiology and Preventive Medicine at Monash University in Melbourne, Australia, and another two years in the School of Computer Science at McGill University in Montreal, Canada. Dr. Shortreed collaborates with scientists in a broad range of research areas including alcohol use, cancer screening, and medication safety, and now works alongside researchers in mental and behavioral health.

Dr. Trivedi is a Professor of Psychiatry, Chief of the Division of Mood Disorders, and the Founding Director of the Center for Depression Research and Clinical Care at UT Southwestern Medical Center. He holds the Betty Jo Hay Distinguished Chair in Mental Health and the Julie K. Herse Chair for Depression Research and Clinical Care. He earned his MS and MD in Baroda, India, completing his residencies in Psychiatry at University General Hospital, Baroda, India and Henry Ford Hospital. Certified by the American Board of Psychiatry and Neurology, Dr. Trivedi focuses on developing and validating biosignatures of depression as well as the pharmacological, psychosocial, and nonpharmacological treatments for depression. He has been a principal investigator on numerous translational projects and clinical trials and has one of the longest running longitudinal research studies on depression.

Dr. Unützer is a board-certified psychiatrist and a Professor of Psychiatry and Behavioral Sciences at the University of Washington. He completed his medical degree at the Vanderbilt University School of Medicine and his medical residency at UCLA. His work focuses on innovative models of care that integrate mental health and general medical services, and on translating research from evidence-based mental health care into effective clinical and public health practice. He has more than 300 scholarly publications and is the recipient of numerous federal and foundation grants and awards for his research to improve the health and mental health of populations through patient-centered integrated mental health services. Dr. Unützer works with various national and international organizations to improve behavioral health care for diverse populations, most notably having served as Senior Scientific Advisor to the World Health Organization and as an advisor to the President’s New Freedom Commission on Mental Health.

Dr. Merrick has nearly 20 years of clinical, research, and leadership experience related to the etiology, course, and prevention of child abuse and neglect. She is currently the President and CEO of Prevent Child Abuse America, the nation's oldest nonprofit organization dedicated to the primary prevention of child abuse and neglect.

Previously, Dr. Merrick was a senior epidemiologist at the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention (CDC), in Atlanta, and served on a detail in the Office of the Commissioner at the Children's Bureau in the Administration for Children and Families. In partnership with the U.S. Department of Health and Human Services' Office of Child Abuse and Neglect, she served as the lead scientist for the Adverse Childhood Experiences (ACE) study at CDC for 8 years. Dr. Merrick successfully leverages her clinical and research experiences to communicate and disseminate the critical public health importance of preventing early adversity to key stakeholders with diverse priorities, backgrounds, and knowledge, including legislators, business and civic leaders, and members of the academic and medical communities.

Dr. Merrick received her BA in Psychology, magna cum laude, from the University of Pennsylvania, and her master's and doctoral degrees in Clinical Psychology from the San Diego State University/University of California, San Diego, joint doctoral program in clinical psychology, where she served as a program coordinator for the San Diego site of the Longitudinal Studies on Child Abuse and Neglect Consortium. Dr. Merrick was a National Institutes of Health-funded postdoctoral fellow at the University of Miami Child Protection Team (CPT), where she was involved in a multi-site program of research that examined child maltreatment risk and protective factors in families evaluated by CPTs across the state of Florida.

Dr. Merrick is married and has two young children who keep her grounded, thankful, and hopeful for a brighter future for all children.

Dr. Abdi is a Clinical Social Worker and an expert in refugee trauma and resilience. She has worked for more than 20 years with refugee youth and families in the diaspora. Her areas of focus include building individual, family, and community resilience, improving systems of care responsiveness to the needs of refugee and immigrant communities, trauma systems therapy, and culturally responsive interventions. She is the co-developer of Community Connect, a multidisciplinary team-based intervention that worked with youth up to the age of 24 years of age who are at risk for violence of any type. She is also the Primary Investigator of the project, RAJO (Somali for hope) in Canada, funded by the Public Safety Agency in Canada to support positive outcomes for Somali-Canadian youth. This 5-year, multi-million-dollar project will be evaluated to test the impact of the intervention on youth outcomes.

Dr. Abdi previously served for over 12 years as Associate Director for Community Relations of the Refugee Trauma and Resilience Center at Boston Children's Hospital and Adjunct Professor of Boston College. She earned her PhD in Sociology and Social Work and a Master's degree in Social Work from Boston University and a second Master’s degree in Communications and Media Studies from Carleton University in Ottawa, Canada.

She is the co-author of the recently published book, Mental Health Practice with Immigrant and Refugee Youth: A Socioecological Framework (APA, 2019).

Dr. Larissa Avilés-Santa is the Director of the Division of Clinical and Health Services Research at National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH). In her current role, she works with her great team on fostering research aimed at improving health outcomes of health disparities populationswithin the context of healthcare systems.

Prior to joining NIMHD, she worked at the National Heart, Lung, and Blood Institute from 2006 to 2019 as the Project Director for the Hispanic Community Health Study/Study of Latinos. In addition, she has participated in multiple NIH-wide committees and working groups addressing minority health, diabetes mellitus and its complications, and women's health. In 2015, she founded the NIH Hispanic Health Research Scientific Interest Group.

She has coauthored multiple publications on different Hispanic health topics and is a frequent guest lecturer at academic and other scientific venues within and outside of the NIH. In 2017, Dr. Avilés-Santa was the field coordinator of the post-hurricanes Irma and María recovery of the health and social services of the entire country of Puerto Rico. She worked in this capacity during the first six and a half months of recovery work coordinated by the HHS.

Dr. Avilés-Santa earned her medical degree from the University of Puerto Rico School of Medicine, and completed a residency in internal medicine at the University Hospital in San Juan. She completed her fellowship in endocrinology at the University of Texas (UT) Southwestern Medical Center, where she joined the faculty of the Endocrine Division. She also earned a Master's degree at the UT School of Public Health.

In addition to his leadership roles at the Hospital for Sick Children, the SickKids Centre for Global Child Health, and Aga Khan University in Pakistan, Dr. Bhutta holds adjunct professorships at several universities, including Johns Hopkins University and the London School of Hygiene & Tropical Medicine. Dr. Bhutta is a Distinguished National Professor of the Government of Pakistan, Co-Chair of the Maternal and Child Health Oversight Committee of the World Health Organization Eastern Mediterranean Region, Chairman of the Coalition of Centres in Global Child Health, Past President of the International Pediatric Association, and a leading voice for health professionals supporting integrated maternal, newborn, and child health globally.

Dr. Bhutta leads large research groups in Toronto, Karachi, and Nairobi with a special interest in scaling up evidence-based, community setting interventions and implementation of RMNCAH&N interventions in humanitarian contexts. His work with community health workers has influenced maternal and newborn outreach programs for marginalized populations internationally, and his group’s work with the WHO and PMNCH is guiding global policy on essential interventions for women, children, and adolescents.

Dr. Bhutta obtained his MBBS from the University of Peshawar and his PhD from the Karolinska Institute. He is a Fellow of the Royal College of Physicians, the Royal College of Paediatrics and Child Health, and the Pakistan Academy of Sciences. He was recently awarded the honour of Fellow of the Royal Society and honorary Fellow of the American Academy of Pediatrics. Among many honors, in 2016, Dr. Bhutta received the World Academy of Sciences 2016 prize in Medical Sciences.

Dr. Keith Dobson is a professor of Clinical Psychology who leads University of Calgary’s Depression Research Laboratory. His research interests are in Clinical Psychology, Cognitive Behaviour Therapy, Depression and stigma. Dr. Dobson also examined psychological approaches and treatments for adults in primary care with Adverse Childhood Experiences. Further, he has written about developments in professional psychology and ethics, and has been actively involved in organized psychology in Canada, including a term as President of the Canadian Psychological Association. Dr. Dobson is also a Principal Investigator for the Opening Minds program of the Mental Health Commission of Canada, with a focus on stigma reduction related to mental disorders in the workplace. His work has yielded more than 300 peer-reviewed published articles, 80 chapters, 17 books, and presentations in many parts of the world. He is a Past-President of both the Academy of Cognitive Therapy and the International Association for Cognitive Psychotherapy. Among other awards, he has been given the Canadian Psychological Association's Award for Distinguished Contributions to the Profession of Psychology, the Donald O. Hebb Award for Distinguished Contributions to the Science of Psychology, and the Award for Distinguished Contributions to the International Development of Psychology. Dr. Dobson received a PhD and Master's degree in Psychology from the University of Western Ontario, London and a Bachelor's degree in Psychology/Sociology from the University of Alberta, Edmonton.

Dr. Edwards has been committed to organized medicine for over 30 years, holding prominent positions in local, state, and national associations. She is past president of the National Medical Association, MedChi, Baltimore City Medical Society, and Monumental City Medical Society.

Putting patients first has been this physician's mission in her 10-year tenure on the board of CRISP, the regional health information center in Maryland.

Joining AMA in 1994, Dr. Edwards was appointed to the inaugural governing council of the Women Physicians Congress and has served on reference committees, task forces and chaired the AMA Council on Constitution and Bylaws.

After completing active duty in the Navy, Dr. Edwards founded an internal medicine practice in Baltimore, where she is the managing partner. She retired from the U.S. Navy Reserves at the rank of commander after 24 years of service. In addition to her busy private practice and AMA responsibilities, Dr. Edwards held senior management positions at the National Association for the Advancement of Colored People Health Advocacy Division and at the Sickle Cell Disease Association of America.

Elected to the Board of Trustees in 2016 and re-elected in 2020, Dr. Edwards has demonstrated hard work, leadership skills, and consensus building. She chaired the Task Force on Health Equity, resulting in the establishment of the AMA Center on Health Equity.

Dr. Edwards knows the balance needed in a physician's work life and the need to always be an advocate for patients in the delivery of quality care.

Dr. Gee directs the Clinical Affective Neuroscience and Development Laboratory at Yale University. She received her BA in Psychological and Brain Studies from Dartmouth College and her PhD in clinical psychology from UCLA. Prior to joining the faculty at Yale, Dr. Gee completed her clinical internship and postdoctoral training at Weill Cornell Medical College. Her research focuses on child and adolescent mental health, with primary goals to delineate typical and atypical trajectories of brain development, elucidate how early adversity influences sensitive periods of development, and translate knowledge of the developing brain to optimize interventions for children and adolescents with anxiety and stress-related disorders. Dr. Gee's research is funded by the National Institutes of Health, the Brain & Behavior Research Foundation, the Jacobs Foundation, and the American Psychological Association. She has received broad recognition for her work, including an NIH Director's Early Independence Award, the Janet Taylor Spence Award for Transformative Early Career Contributions from the Association of Psychological Science, and the American Psychological Association's Early Career Award for Outstanding Contributions to Children, Youth, and Families.

Dr. Ham is a Clinical Psychologist, Associate Professor in Psychiatry, and Director of the Center for Child Trauma and Resilience at the Icahn School of Medicine at Mount Sinai. He receives federal and local grants to create and advance trauma-informed practices throughout multiple service systems including education, foster care, medical health, and criminal justice. His most recent funding from SAMHSA, the NYC DOE, and the Manhattan District Attorney's office are being used to create a trauma-informed adolescent substance abuse recovery and prevention program, a complex trauma treatment program inside the Mount Sinai Health System, crime victims treatment centers and trauma-informed community schools. He is a highly sought trainer and consultant on trauma-informed engagement and maintains an active clinical practice at Mount Sinai Beth Israel for children, families, and adults with a particular focus on using moment-to-moment relationship-based interventions that enhance attachment to overcome trauma and improve mental health. He received his PhD at the University of Massachusetts Boston and completed an internship at Massachusetts General Hospital and a fellowship at Children's Hospital Boston, both of which were also part of Harvard Medical School.

Dr. Hoyme serves as Senior Advisor in Genetics/Genomic Medicine at Sanford Health, the University of South Dakota Sanford School of Medicine, and the University of Arizona Health Sciences. He also serves as Medical Director of the Sanford Children's Genomic Medicine Consortium, a formal collaborative in pediatric precision medicine among ten major children's hospitals. Previously, he functioned as Department Chair of Pediatrics at the Sanford School of Medicine, President of Sanford Research and Chief Academic Officer for Sanford Health. He has held academic and leadership posts at the Stanford University School of Medicine, Lucile Packard Children's Hospital, and the University of Vermont College of Medicine.

He earned his BA summa cum laude from Augustana University in Sioux Falls and his MD from the University of Chicago Pritzker School of Medicine. He completed his residency in Pediatrics and Clinical Genetics fellowship training at the University of California, San Diego. He is board certified in Pediatrics, Clinical Genetics, and Clinical Cytogenetics.

He is the recipient of myriad awards in research, teaching, and mentorship, including the Western Society for Pediatric Research's Joseph W. St. Geme Jr. Education Award, the National Organization on Fetal Alcohol Syndrome Excellence Award, the American Academy of Pediatrics David W. Smith Education and Mentorship Award, and the Fetal Alcohol Spectrum Disorders Study Group's Henry Rosett Award for Lifetime Contributions to FASD Research. His research focuses on Pediatric Genetics/Precision Medicine and Fetal Alcohol Spectrum Disorders (FASD). Recently, he was first author of revised expert consensus diagnostic guidelines for FASD based on evaluation of over 10,000 children world-wide spanning more than 20 years.

Dr. Kerig received her doctorate in Clinical Psychology from the University of California at Berkeley with a specialization in children and families and currently is a Professor in the Clinical Psychology program at the University of Utah where she directs the Risk to Resilience Laboratory. She also serves as the Editor in Chief of the Journal of Traumatic Stress. Dr. Kerig is an author of over 185 scholarly journal articles, books, chapters, and journal special issues devoted to understanding the developmental psychopathology of risk, recovery, and resilience among children, adolescents, and families coping with adversity in the context of a range of traumatic stressors, including childhood maltreatment, exposure to interparental conflict and violence, and intimate partner abuse. Her current program of research is focused on investigating the mechanisms accounting for the link between childhood trauma exposure and adolescent delinquency, with attention to potential underlying psychophysiological, cognitive, emotional, and interpersonal processes. She has a special interest in risk factors specific to traumatized girls in the justice system and the roles of intersectionality in regard to gender, race, class, and sexual minority status. Dr. Kerig also is a co-Director of the Center for Trauma Recovery and Juvenile Justice, a National Child Traumatic Stress Network center whose mission is to develop and disseminate trauma-informed assessment and intervention strategies to the systems that serve at-risk youth, while protecting staff from the potential adverse effects of secondary traumatic stress.

Dr. Lengua is a Child Clinical Psychologist studying the effects of stress and adversity on children, examining risk and protective factors that contribute to children's resilience or vulnerability. She examines children's neurobiological stress responses, temperament, coping, parenting, and family contexts as risk and protective factors that account for the effects of adversity on children's social, emotional, and academic well-being.

Dr. Lengua has been an investigator on several federally-funded projects examining the development of executive function (NICHD), the effects of low income, neighborhood, family, and parenting on neurobiological systems of self-regulation, and their effects on preschool and preadolescent children's social, emotional and academic development (NICHD, NIMH), neighborhood, family and peer effects on adolescent substance use (NIDA), and childhood risk factors for the emergence of adult mental health problems (NIDA). Dr. Lengua is the author of over 100 published papers. She serves on the steering committee for the CDC-funded Washington State Essentials for Childhood Initiative, collaborated with the Harvard Center for the Developing Child's Frontiers of Innovation, and has served on the Board of Trustees for Neighborhood House, a nonprofit anti-poverty organization.

Dr. Lloyd Michener serves as a Professor of Family Medicine and Community Health at Duke School of Medicine; Clinical Professor at Duke School of Nursing; and Adjunct Professor at UNC Gillings School of Public Health. He also serves as Chair of the Board of the Foundation for Health Leadership and Innovation and is a member of the National Academies of Medicine Workgroup on Assessing Meaningful Community Engagement.

He has served as Director of the "Practical Playbook", with the support of the deBeaumont Foundation, CDC, and HRSA, linking health care, public health, and communities across the country. In addition, he served as Chair of the Department of Community & Family Medicine at Duke for more than two decades and was the founding director of the Duke Center for Community Research.

Nationally, Dr. Michener has served as the founding Co-Chair of the Community Engagement Steering Committee for the Clinical and Translational Science Awards of the NIH, and as President of the Association for Prevention, Teaching and Research (APTR). He has been a member of the National Academies Institute of Medicine Committee on Integrating Primary Care and Public Health, the Board of Directors of the Association of Academic Medical Colleges, and the NIH Council for Complementary and Alternative Medicine. Awards include Phi Beta Kappa, Alpha Omega Alpha, the Mead-Johnson Award from the American Academy of Family Physicians, and the Duncan Clark Award from APTR.

Dr. Michener is a graduate of Oberlin College, Harvard Medical School, and residency and fellowship in Family Medicine at Duke.

Dr. Nelson's research interests center on a variety of problems in Developmental Cognitive Neuroscience, including the development of social perception; developmental trajectories to autism; and the effects of early adversity on brain and behavioral development. He chaired the John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development and served on the National Academy of Sciences (NAS) panels that wrote From Neurons to Neighborhoods, and New Directions in Child Abuse and Neglect Research. In total, Dr. Nelson has published over 400 peer-reviewed journal articles and book chapters, has edited eight books, and written three books. Among his many honors he has received the Leon Eisenberg award from Harvard Medical School, an honorary Doctorate from Bucharest University (Romania), and the Ruane Prize for Child and Adolescent Psychiatric Research from the Brain & Behavior Research Foundation. He was a resident fellow at the Rockefeller Foundation Bellagio Center (Italy) and has been elected to the American Academy of Arts and Sciences, the National Academy of Medicine, and the British Academy.

Kenneth S. Ramos, MD, PhD, is an accomplished physician-scientist and transformational leader, with designations in the National Academy of Sciences and National Academy of Medicine. He is recognized throughout the world for his scientific contributions in the areas of Genomics, Precision Medicine, and Toxicology.

With formal training in Pharmaceutical Sciences, Chemistry, Biochemistry, Pharmacology, and Medicine, Dr. Ramos is helping to steer the changing landscape of medicine and healthcare. He leads several translational, clinical, and educational programs that integrate diverse approaches to elucidate genomic mechanisms of disease. Dr. Ramos has provided academic, executive, administrative, and scientific leadership in Genetics and Genomic Medicine and Toxicology at several institutions, and over the course of his career has influenced the career of numerous clinicians and scientists engaged in medical, veterinary, and pharmaceutical practice. He is committed to initiatives that advance modern technological applications to improve quality of healthcare and reduce disease burden and health-associated costs.

Dr. Ramos's research has paved the way for ground breaking research on LINE-1 retroelements and their role in chromatin remodeling, DNA damage and repair, and genetic reprogramming. His group was the first to establish a role for retinoblastoma proteins as master regulators of epigenetic silencing of LINE-1 and later characterized novel targets for regulation of cancer cells. He is currently examining the utility of circulating LINE-1 protein as prognostic and diagnostic biomarkers of lung cancer, which combined with imaging may improve precision for early cancer detection. This knowledge is being used to develop targeted therapies for lung cancer.

Arash Shaban-Nejad, PhD, MPH, MS, FAMIA is an Associate Professor at the University of Tennessee Health Science Center and Director of Population and Precision Health within the Center for Biomedical Informatics. His research integrates epidemiology, biomedical informatics, artificial intelligence, and population health analytics to advance disease surveillance, chronic disease research, and health equity–focused decision-making. Dr. Shaban-Nejad develops and applies advanced analytic methods for high-dimensional health data, real-world evidence applications, and data-driven tools to address structural determinants of health and disparities across diverse clinical populations. He holds doctoral and master’s degrees with training in public health and computational sciences and collaborates across clinical, academic, and public health settings to translate research into policy and practice. He has previously contributed to scientific review and advisory efforts, including service on the ACEs and Depression Selection Committees, and his work continues to promote equity-oriented, data-informed approaches in population and precision health.